
Ifosfamide Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1 g/vial,2 g/vial, 3 g/vial
Reference Brands: Ifex® (US), Holoxan® (EU)
Category: Oncology Cancer Care
Ifosfamide is available in Injection and strengths such as 1 g/vial,2 g/vial, 3 g/vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ifosfamide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Ifosfamide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Ifosfamide Injection is a cytotoxic alkylating agent used in the treatment of germ cell testicular cancer, sarcomas, lymphomas, and other solid tumors. Available in sterile powder form for reconstitution (1 g, 2 g, 3 g vials), our Ifosfamide is manufactured under EU-GMP and USFDA-compliant facilities. Suitable for B2B supply, hospital tenders, private labeling, and licensing agreements, it is supported with full CTD dossiers, CoA, stability data, and GMP certification. Alcohol-free, stable, and ready for international markets, our Ifosfamide injection is ideal for global distributors, procurement agencies, and oncology-focused partners seeking high-quality injectable chemotherapy formulations.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers